Author: Zanata S.M. Luvizon A.C. Batista D.F. Ikegami C.M. Pedrosa F.O. Souza E.M. Chaves D.F.S. Caron L.F. Pelizzari J.V. Laurindo F.R.M. Nakao L.S.
Publisher: Maney Publishing
ISSN: 1743-2928
Source: Redox Report, Vol.10, Iss.6, 2005-12, pp. : 319-323
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Ganguly S. Ashley L.A. Pendleton C.M. Grey R.D. Howard G.C. Castle L.D. Peyton D.K. Fultz M.E. DeMoss D.L.
Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 7, 2008-07 ,pp. :
High-dose ACE inhibitor therapy reduces levels of IL-6
Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. :
By Borg Joseph Phylactides Marios Bartsakoulia Marina Tafrali Christina Lederer Carsten Felice Alexander E Papachatzopoulou Adamantia Kourakli Alexandra Stavrou Eleana F Christou Soteroula Hou Jun Karkabouna Sophia Lappa-Manakou Christina Özgur Zeliha van IJcken Wilfred von Lindern Marieke Grosveld Frank G Georgitsi Marianthi Kleanthous Marina Philipsen Sjaak Patrinos George P
Pharmacogenomics, Vol. 13, Iss. 13, 2012-10 ,pp. :
Semicarbazide-sensitive amine oxidase (SSAO): present and future
By Magyar Kálmán Mészáros Zsuzsa
Inflammopharmacology, Vol. 11, Iss. 2, 2003-06 ,pp. :